Growth Metrics

Enanta Pharmaceuticals (ENTA) EBIT Margin Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3,609.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,536.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -170.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -3,724.00
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 9,525.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9,525.00
Dec 31, 2025 7,837.00
Sep 30, 2025 8,282.00
Jun 30, 2025 3,142.00
Mar 31, 2025 2,781.00
Dec 31, 2024 5,496.00
Sep 30, 2024 -4,048.00
Jun 30, 2024 5,975.00
Mar 31, 2024 2,957.00
Dec 31, 2023 -6,652.00
Sep 30, 2023 -3,077.00
Jun 30, 2023 -2,728.00
Mar 31, 2023 -4,085.00
Dec 31, 2022 -1,727.00
Sep 30, 2022 993.00
Jun 30, 2022 -1,053.00
Mar 31, 2022 -3,332.00
Dec 31, 2021 -7,124.00
Sep 30, 2021 -5,935.00
Jun 30, 2021 -3,401.00
Mar 31, 2021 -10,453.00
Dec 31, 2020 -6,323.00
Sep 30, 2020 -9,625.00
Jun 30, 2020 -13,097.00
Mar 31, 2020 -3,971.00
Dec 31, 2019 -1,538.00
Sep 30, 2019 -3,873.00
Jun 30, 2019 -3,107.00
Mar 31, 2019 -4,156.00
Dec 31, 2018 213.00
Sep 30, 2018 -2,025.00
Jun 30, 2018 21,433.00
Mar 31, 2018 14,438.00
Dec 31, 2017 10,537.00
Sep 30, 2017 9,564.00
Jun 30, 2017 -16,701.00
Mar 31, 2017 -10,176.00
Dec 31, 2016 -14,111.00
Sep 30, 2016 -4,962.00
Jun 30, 2016 -2,247.00
Mar 31, 2016 -8,899.00
Dec 31, 2015 -1,712.00
Sep 30, 2015 22,746.00
Jun 30, 2015 -6,830.00
Mar 31, 2015 32,201.00
Dec 31, 2014 70,168.00
Sep 30, 2014 14,651.00
Jun 30, 2014 33,635.00
Mar 31, 2014 9,717.00
Dec 31, 2013 -68,973.00
Sep 30, 2013 -12,803.00
Jun 30, 2013 -11,458.00
Mar 31, 2013 -42,231.00